Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab

View/Open
Volume
30
Pagination
1763 - 1766
DOI
10.1038/leu.2016.41
Journal
LEUKEMIA
Issue
8
ISSN
0887-6924
Metadata
Show full item record
Authors
Freeman, CL; Dixon, M; Houghton, R; Kreuzer, K-A; Fingerle-Rowson, G; Herling, M; Humphrey, K; Boettcher, S; de Costa, CS; Iglesias, V
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/28865
Collections
Licence information
CC-BY-NC-ND
Copyright statements
© 2016, Rights Managed by Nature Publishing Group